TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]
Brief Summary: Investigation into the long-term safety and efficacy of OPC-41061 in repeated oral administrations at doses of 15 mg twice daily in patients with ADPKD who completed the preceding dose-finding study (156-04-001).


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: OPC-41061 | Intervention Type: DRUG; Name: OPC-41061; Assigned to Arm(s): 1
B: Arm Label: Study A, Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lisinopril, Drug: Telmisartan, Other: Standard Blood Pressure Control | Arm Label: Study A, Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lisinopril, Drug: Telmisartan, Other: Low Blood Pressure Control | Arm Label: Study A, Arm 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Lisinopril, Drug: Placebo, Other: Standard Blood Pressure Control | Arm Label: Study A, Arm 4; Type: PLACEBO_COMPARATOR; Interventions: Drug: Lisinopril, Drug: Placebo, Other: Low Blood Pressure Control | Intervention Type: DRUG; Name: Lisinopril; Assigned to Arm(s): Study A, Arm 1, Study A, Arm 2, Study A, Arm 3, Study A, Arm 4 | Intervention Type: DRUG; Name: Telmisartan; Assigned to Arm(s): Study A, Arm 1, Study A, Arm 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Study A, Arm 3, Study A, Arm 4 | Intervention Type: OTHER; Name: Standard Blood Pressure Control; Assigned to Arm(s): Study A, Arm 1, Study A, Arm 3 | Intervention Type: OTHER; Name: Low Blood Pressure Control; Assigned to Arm(s): Study A, Arm 2, Study A, Arm 4
C: Arm Label: Tolvaptan 45/15 mg/day orally for up to 4 years; Type: EXPERIMENTAL; Interventions: Drug: Tolvaptan | Arm Label: Tolvaptan 60/30 mg/day orally for up to 4 years; Type: EXPERIMENTAL; Interventions: Drug: Tolvaptan | Intervention Type: DRUG; Name: Tolvaptan; Assigned to Arm(s): Tolvaptan 45/15 mg/day orally for up to 4 years, Tolvaptan 60/30 mg/day orally for up to 4 years
D: Arm Label: Everolimus + octreotide LAR; Type: ACTIVE_COMPARATOR; Interventions: Drug: Everolimus, Drug: Octreotide LAR | Arm Label: Octreotide LAR; Type: ACTIVE_COMPARATOR; Interventions: Drug: Octreotide LAR | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): Everolimus + octreotide LAR | Intervention Type: DRUG; Name: Octreotide LAR; Assigned to Arm(s): Everolimus + octreotide LAR, Octreotide LAR

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Randomized, Controlled, Observer-blind, Multicenter Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Doses of a Monovalent A/H5N1 Influenza Vaccine Adjuvanted With MF59 (Fluad-H5N1) in Adult and Elderly Subjects
Brief Summary: The present study, phase III, randomized, controlled, observer-blind, multicenter study, will evaluate safety, tolerability and immunogenicity of two doses of an adjuvanted monovalent influenza vaccine compared with an adjuvanted interpandemic trivalent influenza vaccine in a population of healthy adult and elderly subjects.


Options:
A: Arm Label: Trivalent Influenza vaccine; Type: ACTIVE_COMPARATOR; Interventions: Biological: Trivalent influenza vaccine | Arm Label: Normal saline; Type: PLACEBO_COMPARATOR; Interventions: Biological: Normal saline | Intervention Type: BIOLOGICAL; Name: Trivalent influenza vaccine; Assigned to Arm(s): Trivalent Influenza vaccine | Intervention Type: BIOLOGICAL; Name: Normal saline; Assigned to Arm(s): Normal saline
B: Arm Label: TIV + aH5N1; Type: EXPERIMENTAL; Interventions: Biological: Trivalent influenza virus vaccine (TIV), Biological: Adjuvanted monovalent influenza virus vaccine (aH5N1) | Arm Label: PL + aTIV; Type: ACTIVE_COMPARATOR; Interventions: Biological: Placebo (PL), Biological: Adjuvanted trivalent influenza virus vaccine (aTIV) | Intervention Type: BIOLOGICAL; Name: Placebo (PL); Assigned to Arm(s): PL + aTIV | Intervention Type: BIOLOGICAL; Name: Trivalent influenza virus vaccine (TIV); Assigned to Arm(s): TIV + aH5N1 | Intervention Type: BIOLOGICAL; Name: Adjuvanted monovalent influenza virus vaccine (aH5N1); Assigned to Arm(s): TIV + aH5N1 | Intervention Type: BIOLOGICAL; Name: Adjuvanted trivalent influenza virus vaccine (aTIV); Assigned to Arm(s): PL + aTIV
C: Intervention Type: BIOLOGICAL; Name: Influenza virus vaccine (Fluviral); Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: Saline placebo; Assigned to Arm(s): N/A
D: Arm Label: treatment; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Lactobacillus rhamnosus, Biological: Influenza Virus Vaccine Live, Intranasal | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: placebo control, Biological: Influenza Virus Vaccine Live, Intranasal | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus rhamnosus; Assigned to Arm(s): treatment | Intervention Type: DIETARY_SUPPLEMENT; Name: placebo control; Assigned to Arm(s): placebo | Intervention Type: BIOLOGICAL; Name: Influenza Virus Vaccine Live, Intranasal; Assigned to Arm(s): placebo, treatment

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot of Customized Continuous Care Management of Obesity in Pre-Diabetics
Brief Summary: The purpose of the E-LITE Study is to evaluate the feasibility and potential effectiveness of two lifestyle interventions in a community based primary care setting. The study aims to assess how changes in diet, exercise, and behavioral self-management affect weight and related risk factors for adults at risk for diabetes and cardiovascular disease.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Virtual Coach software | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Activity monitor and website | Intervention Type: OTHER; Name: Virtual Coach software; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Activity monitor and website; Assigned to Arm(s): Control
B: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Self-Management Program; Type: EXPERIMENTAL; Interventions: Behavioral: Self-management program (SM) | Arm Label: Care Management Program; Type: EXPERIMENTAL; Interventions: Behavioral: Care management program (CM) | Intervention Type: BEHAVIORAL; Name: Self-management program (SM); Assigned to Arm(s): Self-Management Program | Intervention Type: BEHAVIORAL; Name: Care management program (CM); Assigned to Arm(s): Care Management Program
C: Arm Label: A - GWL; Type: EXPERIMENTAL; Interventions: Behavioral: Group weight loss program | Arm Label: B - GWL+SWA; Type: EXPERIMENTAL; Interventions: Other: Group weight loss program plus use of the Senseware Armband | Arm Label: C - SWA Alone; Type: EXPERIMENTAL; Interventions: Device: Use of the senseware armband alone program | Arm Label: D - Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Group weight loss program; Assigned to Arm(s): A - GWL | Intervention Type: OTHER; Name: Group weight loss program plus use of the Senseware Armband; Assigned to Arm(s): B - GWL+SWA | Intervention Type: DEVICE; Name: Use of the senseware armband alone program; Assigned to Arm(s): C - SWA Alone
D: Arm Label: Podcasting + mobile media; Type: EXPERIMENTAL; Interventions: Behavioral: Podcasting + mobile media | Arm Label: Podcasting; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Podcasting + mobile media | Intervention Type: BEHAVIORAL; Name: Podcasting + mobile media; Assigned to Arm(s): Podcasting, Podcasting + mobile media

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot of Customized Continuous Care Management of Obesity in Pre-Diabetics
Brief Summary: The purpose of the E-LITE Study is to evaluate the feasibility and potential effectiveness of two lifestyle interventions in a community based primary care setting. The study aims to assess how changes in diet, exercise, and behavioral self-management affect weight and related risk factors for adults at risk for diabetes and cardiovascular disease.


Options:
A: Arm Label: Moderate lifestyle intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Moderate Lifestyle Intervention | Arm Label: Intensive lifestyle intervention; Type: EXPERIMENTAL; Interventions: Other: Intensive lifestyle intervention | Intervention Type: OTHER; Name: Moderate Lifestyle Intervention; Assigned to Arm(s): Moderate lifestyle intervention | Intervention Type: OTHER; Name: Intensive lifestyle intervention; Assigned to Arm(s): Intensive lifestyle intervention
B: Arm Label: Standard Behavioral Treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Behavioral Treatment | Arm Label: SBT+LOV Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Behavioral Treatment, Behavioral: SBT+LOV | Intervention Type: BEHAVIORAL; Name: Standard Behavioral Treatment; Assigned to Arm(s): SBT+LOV Group, Standard Behavioral Treatment | Intervention Type: BEHAVIORAL; Name: SBT+LOV; Assigned to Arm(s): SBT+LOV Group
C: Intervention Type: BEHAVIORAL; Name: Behavioral weight loss treatment; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Behavioral and home environment weight loss treatment; Assigned to Arm(s): N/A
D: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Self-Management Program; Type: EXPERIMENTAL; Interventions: Behavioral: Self-management program (SM) | Arm Label: Care Management Program; Type: EXPERIMENTAL; Interventions: Behavioral: Care management program (CM) | Intervention Type: BEHAVIORAL; Name: Self-management program (SM); Assigned to Arm(s): Self-Management Program | Intervention Type: BEHAVIORAL; Name: Care management program (CM); Assigned to Arm(s): Care Management Program

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot of Customized Continuous Care Management of Obesity in Pre-Diabetics
Brief Summary: The purpose of the E-LITE Study is to evaluate the feasibility and potential effectiveness of two lifestyle interventions in a community based primary care setting. The study aims to assess how changes in diet, exercise, and behavioral self-management affect weight and related risk factors for adults at risk for diabetes and cardiovascular disease.


Options:
A: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Self-Management Program; Type: EXPERIMENTAL; Interventions: Behavioral: Self-management program (SM) | Arm Label: Care Management Program; Type: EXPERIMENTAL; Interventions: Behavioral: Care management program (CM) | Intervention Type: BEHAVIORAL; Name: Self-management program (SM); Assigned to Arm(s): Self-Management Program | Intervention Type: BEHAVIORAL; Name: Care management program (CM); Assigned to Arm(s): Care Management Program
B: Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Structured Education | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Written Information | Intervention Type: BEHAVIORAL; Name: Structured Education; Assigned to Arm(s): Lifestyle counseling | Intervention Type: BEHAVIORAL; Name: Written Information; Assigned to Arm(s): Control
C: Arm Label: Lifestyle Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle Intervention | Arm Label: Diabetes Support and Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Diabetes Support and Education | Intervention Type: BEHAVIORAL; Name: Lifestyle Intervention; Assigned to Arm(s): Lifestyle Intervention | Intervention Type: BEHAVIORAL; Name: Diabetes Support and Education; Assigned to Arm(s): Diabetes Support and Education
D: Arm Label: 1 Original Lifestyle; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: DPPOS Group Lifestyle, Behavioral: DPPOS Boost Lifestyle, Behavioral: Intensive Lifestyle Group Session | Arm Label: 2 Original Metformin; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: DPPOS Group Lifestyle, Drug: Metformin, Behavioral: Intensive Lifestyle Group Session | Arm Label: 3 Original Placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: DPPOS Group Lifestyle, Behavioral: Intensive Lifestyle Group Session | Intervention Type: BEHAVIORAL; Name: DPPOS Group Lifestyle; Assigned to Arm(s): 1 Original Lifestyle, 2 Original Metformin, 3 Original Placebo | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): 2 Original Metformin | Intervention Type: BEHAVIORAL; Name: DPPOS Boost Lifestyle; Assigned to Arm(s): 1 Original Lifestyle | Intervention Type: BEHAVIORAL; Name: Intensive Lifestyle Group Session; Assigned to Arm(s): 1 Original Lifestyle, 2 Original Metformin, 3 Original Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Dental Brushing for Preventing Ventilator-Associated Pneumonia
Brief Summary: Poor oral hygiene is associated with respiratory pathogen colonization and secondary lung infection.The possible association between oral care and incidence of VAP, and the role of dental plaque, mouth and tracheal colonization have not been firmly established. The investigators' hypothesis was that improving oral care with electrical toothbrushing might be effective in reducing the incidence of VAP.


Options:
A: Arm Label: Raspall; Type: EXPERIMENTAL; Interventions: Procedure: Toothbrushing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Toothbrushing; Assigned to Arm(s): Raspall
B: Arm Label: Oral Chlorhexidine Mouth Rinse; Type: OTHER; Interventions: Other: Chlorhexidine Mouth Rinse | Arm Label: De-Adoption of Oral Chlorhexidine Mouth Rinse; Type: EXPERIMENTAL; Interventions: Other: Chlorhexidine Mouth Rinse De-Adoption | Intervention Type: OTHER; Name: Chlorhexidine Mouth Rinse; Assigned to Arm(s): Oral Chlorhexidine Mouth Rinse | Intervention Type: OTHER; Name: Chlorhexidine Mouth Rinse De-Adoption; Assigned to Arm(s): De-Adoption of Oral Chlorhexidine Mouth Rinse
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Oral Care | Arm Label: B; Type: EXPERIMENTAL; Interventions: Procedure: Comprehensive Oral Care | Intervention Type: PROCEDURE; Name: Standard Oral Care; Assigned to Arm(s): A | Intervention Type: PROCEDURE; Name: Comprehensive Oral Care; Assigned to Arm(s): B
D: Arm Label: Pre-intubation CHX; Type: EXPERIMENTAL; Interventions: Procedure: Pre-intubation CHX | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Control | Intervention Type: PROCEDURE; Name: Pre-intubation CHX; Assigned to Arm(s): Pre-intubation CHX | Intervention Type: PROCEDURE; Name: Control; Assigned to Arm(s): Control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Dental Brushing for Preventing Ventilator-Associated Pneumonia
Brief Summary: Poor oral hygiene is associated with respiratory pathogen colonization and secondary lung infection.The possible association between oral care and incidence of VAP, and the role of dental plaque, mouth and tracheal colonization have not been firmly established. The investigators' hypothesis was that improving oral care with electrical toothbrushing might be effective in reducing the incidence of VAP.


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Oral Care | Arm Label: B; Type: EXPERIMENTAL; Interventions: Procedure: Comprehensive Oral Care | Intervention Type: PROCEDURE; Name: Standard Oral Care; Assigned to Arm(s): A | Intervention Type: PROCEDURE; Name: Comprehensive Oral Care; Assigned to Arm(s): B
B: Arm Label: Raspall; Type: EXPERIMENTAL; Interventions: Procedure: Toothbrushing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Toothbrushing; Assigned to Arm(s): Raspall
C: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: oral hygiene | Intervention Type: OTHER; Name: oral hygiene; Assigned to Arm(s): 2 | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): 1
D: Arm Label: Toothbrushing with a manual brush; Type: EXPERIMENTAL; Interventions: Device: Toothbrushing with a manual brush | Arm Label: No toothbrushing; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Toothbrushing with a manual brush; Assigned to Arm(s): Toothbrushing with a manual brush

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Dengue Vaccine in Healthy Children Aged 4 to 11 Years in Thailand
Brief Summary: The primary objective of the study was to assess the efficacy of CYD dengue vaccine after three injections in preventing symptomatic virologically-confirmed dengue (VCD) cases, regardless of the severity, due to any of the four serotypes in children aged 4 to 11 years at the time of inclusion.

Secondary objectives included to assess:

* Vaccine efficacy against severe VCD cases
* Vaccine efficacy against VCD cases following at least two injections with CYD dengue vaccine
* Immune response to CYD dengue vaccine
* Safety profile of CYD dengue vaccine. Safety assessments include solicited reactions within 7 or 14 days after each injection, unsolicited adverse events within 28 days after each injection, and serious adverse events during the study period.

Other objectives included:

* Vaccine efficacy against VCD cases following at least one injection with CYD dengue vaccine
* Vaccine efficacy against VCD cases due to each serotype
* Participants with clinical signs and symptoms for VCD


Options:
A: Arm Label: CYD Dengue Vaccine Group; Type: EXPERIMENTAL; Interventions: Biological: Live, attenuated, dengue serotype 1, 2, 3, 4 virus | Arm Label: Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo: (NaCl) 0.9% solution | Intervention Type: BIOLOGICAL; Name: Live, attenuated, dengue serotype 1, 2, 3, 4 virus; Assigned to Arm(s): CYD Dengue Vaccine Group | Intervention Type: BIOLOGICAL; Name: Placebo: (NaCl) 0.9% solution; Assigned to Arm(s): Placebo Group
B: Arm Label: CYD Dengue Vaccine Group; Type: EXPERIMENTAL; Interventions: Biological: CYD Dengue Vaccine | Arm Label: Control Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Inactivated rabies virus vaccine, Biological: Placebo | Intervention Type: BIOLOGICAL; Name: CYD Dengue Vaccine; Assigned to Arm(s): CYD Dengue Vaccine Group | Intervention Type: BIOLOGICAL; Name: Inactivated rabies virus vaccine; Assigned to Arm(s): Control Group | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Control Group
C: Arm Label: Dengue Vaccine Group; Type: EXPERIMENTAL; Interventions: Biological: Live, attenuated, dengue serotype 1, 2, 3, 4 virus | Arm Label: Control Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo: Sodium chloride (NaCl) 0.9% | Intervention Type: BIOLOGICAL; Name: Live, attenuated, dengue serotype 1, 2, 3, 4 virus; Assigned to Arm(s): Dengue Vaccine Group | Intervention Type: BIOLOGICAL; Name: Placebo: Sodium chloride (NaCl) 0.9%; Assigned to Arm(s): Control Group
D: Arm Label: Intervention clusters; Type: EXPERIMENTAL; Interventions: Biological: Biological (Male Wolbachia-infected Aedes aegypti) | Arm Label: Non-intervention clusters; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BIOLOGICAL; Name: Biological (Male Wolbachia-infected Aedes aegypti); Assigned to Arm(s): Intervention clusters

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pharmacological Management of Delirium
Brief Summary: The purpose of this study is to develop and test the feasibility of using a specific pharmacological protocol to reduce delirium burden among older adults in the Intensive Care Unit (ICU). The study will test the efficacy of a pharmacological intervention in reducing delirium severity and duration as well as length of stay and mortality compared to usual care.


Options:
A: Arm Label: Dexmedetomidine; Type: EXPERIMENTAL; Interventions: Drug: Dexmedetomidine | Arm Label: Propofol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Propofol | Intervention Type: DRUG; Name: Dexmedetomidine; Assigned to Arm(s): Dexmedetomidine | Intervention Type: DRUG; Name: Propofol; Assigned to Arm(s): Propofol
B: Arm Label: Haloperidol Eligible Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Reduced exposure to anticholinergics, Procedure: Reduced exposure to benzodiazepines, Drug: Haloperidol | Arm Label: Haloperidol Eligible Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Usual care | Arm Label: Haldol-Ineligible Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Reduced exposure to anticholinergics, Procedure: Reduced exposure to benzodiazepines | Arm Label: Haldol Ineligible Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Usual care | Intervention Type: BEHAVIORAL; Name: Reduced exposure to anticholinergics; Assigned to Arm(s): Haldol-Ineligible Arm, Haloperidol Eligible Intervention | Intervention Type: PROCEDURE; Name: Reduced exposure to benzodiazepines; Assigned to Arm(s): Haldol-Ineligible Arm, Haloperidol Eligible Intervention | Intervention Type: DRUG; Name: Haloperidol; Assigned to Arm(s): Haloperidol Eligible Intervention | Intervention Type: PROCEDURE; Name: Usual care; Assigned to Arm(s): Haldol Ineligible Usual Care, Haloperidol Eligible Usual Care
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: dexmedetomidine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: haloperidol | Intervention Type: DRUG; Name: dexmedetomidine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: haloperidol; Assigned to Arm(s): 2
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Rivastigmine | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Rivastigmine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2

Answer: B